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Studies during the past decade have suggested that the respiratory epithelium is principally responsible for maintaining an effective barrier that prevents leakage of fluid and solutes into the lung. This critical function has been ascribed to the junctional complex, which consists of subcellular structures, including tight and intermediate junctions and desmosomes. These structures are common to epithelial cells throughout the respiratory tract (17) and function to inhibit passage of water, electrolytes, and peptides into the airways and alveoli under physiological conditions (24) .
Less attention has been focused on the role of the endothelial barrier for several reasons. Paracellular pores through the endothelial surface are significantly larger than epithelial pores and thus allow freer passage of hydrophilic solutes such as small sugars, electrolytes, and other charged particles under baseline conditions. Estimates of reflection coefficients for serum proteins across the pulmonary endothelium are also significantly less than those of the epithelium (0.5-0.7 vs. 1.0) (5) . Thus it has been concluded that the epithelium is the more important of the two barriers with respect to limiting permeability and preventing capillary leakage.
Despite this, loss of integrity in the endothelial barrier is clearly a prerequisite for development of interstitial edema, is associated with a marked increase in permeability in experimental models, and can trigger ALI-like responses. Recent observations suggest the endothelial barrier may play an important role in the pathogenesis of ALI. Endothelial-specific structures, known as intercellular adherens junction complexes (AJCs), regulate endothelial cell growth patterns and angiogenesis during embryonic development as well as permeability of mature vessels, in response to inflammatory stimuli (7) . These complexes, consisting of vascular endothelial cadherin (VE-cadherin) and components of the "armadillo" protein family, are linked to cytoplasmic microfilaments and join endothelial cells together in either a "tight" or "loose" configuration, rendering the vasculature nonpermeable or permeable, respectively.
The angiogenic growth factors, vascular endothelial growth factor (VEGF), angiopoietin (Ang)-1, Ang-2, and Ang-4 have recently been shown to modulate endothelial permeability of extrapulmonary vessels by altering the state of the AJC (4, 26) . VEGF is a potent endothelial cell mitogen (16) that, through binding to its receptor, VEGF-R2/fetal liver kinase (flk), induces capillary leakage (19) and fluid accumulation in models of ischemic organ injury (27) or systemic inflammation (22) . Recently, adenovirus-mediated expression of VEGF within the lung has been shown to result in profound pulmonary edema (11) . Conversely, Ang-1, a ligand of the endothelium-specific Tie-2 receptor (20) , promotes vessel maturation through its antiapoptotic action (18) and inhibits vessel leakage in response to VEGF or other proinflammatory agents by stabilizing the AJC (20, 22, 23) . The same actions have been proposed for Ang-4, whereas Ang-2 promotes vascular leakage by antagonizing the actions of both Ang-1 and Ang-4 through competitive binding to the Tie-2 receptor.
Based on the observation that the expression of angiogenic growth factors modulates endothelial integrity in several extrapulmonary vascular beds, we hypothesized that there might be a potential association between vascular growth factors, specifically VEGF and the angiopoietins, and the pulmonary edema that occurs during ALI. We tested this hypothesis by examining the expression of VEGF and the angiopoietins in a murine model of intrapulmonary lipopolysaccharide (LPS)-induced ALI. Because responses to inhaled LPS vary among murine strains, we used two strains for these investigations, C57BL/6 and 129/J. Both strains have been demonstrated to develop pulmonary edema and neutrophilic-predominant infiltrates after aerosolized LPS (3), consistent with ALI. We have previously shown that the 129/J strain demonstrates significant lung dysfunction in response to inhaled LPS (10), consistent with a "high responder." The C57BL/6 strain has also been demonstrated to respond to LPS with neutrophilic lung infiltrates and increased pulmonary vascular permeability (3). We reasoned that, if vascular growth factors were important to the development of pulmonary edema in ALI, then that association should be demonstrable in multiple murine strains. Our data indicate that the C57BL/6 strain has a substantially decreased response to inhaled LPS compared with the 129/J strain but that the two strains have similar expression changes among the vascular growth factors after inhaled LPS. Observations summarized here support the notion that changes in the balance between the "proleakage" factor VEGF and "antileakage" factors Ang-1 and Ang-4 might contribute to the pathophysiology of ALI after intrapulmonary endotoxin exposure.
METHODS
Experimental protocol. The experimental protocol was approved by our institution's animal studies committee. Twenty-four 129/J mice (Jackson Laboratories) weighing 18.8 Ϯ 2.1 g (16-24 g) and 24 C57BL/6 mice weighing 22.3 Ϯ 3.4 g (18-32 g) were divided into four groups: 1) control (n ϭ 6); 2) animals exposed to endotoxin (Sigma Chemical) 24 h before study (24-h LPS, n ϭ 6); 3) animals exposed twice, 24 and 48 h before study (48-h LPS, n ϭ 6); and 4) animals exposed four times, 24, 48, 72, and 96 h before study (96-h LPS, n ϭ 6). Additionally, we also studied the bronchoalveolar lavages (BALs) of six 129/J and six C57BL/6 mice 2 h after LPS exposure for cytokine expression. Endotoxin was administered as previously described (10) .
Lung mechanics. Animals were anesthetized and ventilated as previously described (13) . Measurements of lung function were performed using the optimal ventilator waveform method of Lutchen et al. (13) .
BAL cell count. Cells were removed by centrifugation (400 g, 4°C, 10 min), and the supernatant was stored (Ϫ70°C). Recovery (2.82 Ϯ 0.1/3 ml) was similar among groups. Red blood cells were lysed, cytospins were prepared and stained using Diff-Quik (Fisher Scientific, Fairlawn, NJ), and differential and total leukocyte counts were determined by manual counting (10) .
Total protein. Determinations were performed using the bicinchoninic acid microassay method (Pierce Chemical, Rockford, IL) according to the manufacturer's instructions (10) .
BAL cytokines. Tumor necrosis factor (TNF)-␣, interleukin (IL)-1␤, IL-6, IL-10, and interferon (IFN)-␥ were determined in BAL supernatants using an ELISA kit (Endogen, Woburn, MA) according to the manufacturer's instructions (10) .
Immunohistochemistry. Three lungs from each time point were embedded in paraffin, and 3-m-thick sections were cut. Primary goat polyclonal antisera included anti-VEGF (1:400), anti-Ang-4 (1: 100), and anti-Ang-2 (1:400; Santa Cruz Biotechnology, Santa Cruz, CA). Primary antisera used for identifying cell types included the panleukocyte marker monoclonal rat anti-CD45R/B220 (1:25; clone 30-F11; PharMingen, San Diego, CA) and the mesenchymal cell marker monoclonal murine anti-vimentin (1:75; clone V9, Dako, Carpinteria, CA). Negative controls consisted of preabsorbing primary antibody with specific peptide before immunostaining for VEGF. VEGF, CD45, and Ang-2 slides underwent microwave antigen retrieval. Slides were blocked in 10% horse serum and incubated overnight with the primary antibody (4°C). They were then incubated in biotinylated donkey anti-goat secondary antibody (1:500) (for VEGF, Ang-2, Ang-4) or mouse anti-rat (1:500 for CD45; 2 h, 4°C; Jackson Immunoresearch). Endogenous peroxidases were blocked by slide incubation in 3% H 2O2-methanol (10 min, 25°C).
Slides were incubated for 30 min in streptavidin-horseradish peroxidase (1:1,000), and VEGF samples were amplified using biotinylated tyramide (TSA Biotin System; NEN, Boston, MA). Immunopositivity was visualized using chromagen diaminobenzidine (0.025%) in PBS and 0.1% H2O2. All sections were counterstained with 2% methyl green (Sigma).
mRNA measurements. We examined 12 129/J animals, i.e., 3 at each time point (baseline, 24, 48, and 96 h after LPS exposure) and 8 C57BL/6 animals, i.e., 4 at baseline, 2 at 24 h, and 2 at 48 h after LPS exposure. Total lung RNA was extracted after the RNeasy protocol for animal tissues (Qiagen, Valencia, CA). cDNA templates were synthesized by reverse transcriptase (Clontech, Palo Alto, CA). PCR amplification was performed using the following primers: 1) Ang-1, 3Ј-gaggcgcattcgctgta-5Ј (sense) and 3Ј-tgcgtcaaaccaccagc-5Ј; 2) Ang-2, 3Ј-tccagaacacgacggga-5Ј (sense) and 3Ј-atctgggcccatctccga-5Ј; 3) VEGF, 3Ј-caggctgctgtaacgatgaa-5Ј (sense) and 3Ј-tgcgtcaaaccaccagc-5Ј; and 4) ␤-actin, 5Ј-gtgggccgctctaggcaccaa-3Ј (sense) and 5Ј-ctctttgatgtcacgcacgatttc-3Ј. PCR amplification conditions were denaturation at 94°C (5 min) followed by 31 cycles at 1-min denaturation (94°C), 1-min annealing (55°C), and 1-min primer extension (72°C). Final extension was 7 min (72°C). PCR products were resolved in 1.5% agarose gel along with 100-bp DNA ladder.
Statistics. Comparisons at different time points were performed by two-way ANOVA. Statistical significance was defined as P Ͻ 0.05.
RESULTS

Pulmonary physiological response to LPS administration.
Both murine strains demonstrated physiological responses typical of ALI, summarized in Fig. 1 . Airway resistance (R aw ), tissue resistance (expressed in terms of the dissipative modulus G), and dynamic elastance (expressed in terms of the elastic modulus H) at each time point are shown. Both strains demonstrated similar baseline physiology. Within 24 h of LPS exposure, G and H increased significantly in C57BL/6 mice (G: 6.1 Ϯ 0.6 to 15.5 Ϯ 4.7 cmH 2 O/ml, P ϭ 0.002, and H: 44.5 Ϯ 3.4 to 89.4 Ϯ 18.0 cmH 2 O/ml, P ϭ 0.001) and 129/J mice (G: 5.9 Ϯ 0.5 to 13.1 Ϯ 2.2 cmH 2 O/ml, P ϭ 0.003, and H: 32.7 Ϯ 3.3 to 73.2 Ϯ 5.2 cmH 2 O/ml, P ϭ 0.001). R aw did not change significantly after LPS exposure, although total lung resistance, the sum of airway and tissue components, did increase due to the change in the tissue component. In C57BL/6 mice, the physiological response peaked at 24 h and persisted without additional change throughout the 96-h exposure period. In 129/J mice, tissue resistance and lung elastance, that is, the change in pressure per the change in volume, continued to increase with serial LPS exposure such that peak responses were observed at 96 h.
Alteration in BAL cell counts/differentials after nebulized LPS. BAL fluid white blood cell counts and differentials are summarized in Fig. 2 . Before LPS exposure, BAL in both 129/J and C57BL/6 mice revealed a predominance of macrophages, with similar total counts and differentials. 5 cells/ml, P Ͻ 0.001] mice increased by a factor of 10-15 due to a marked influx of neutrophils. In C57BL/6 mice, neutrophil counts continued to increase with each LPS exposure up to 96 h, whereas among 129/J mice, neutrophil counts peaked at 48 h and began to decline toward baseline thereafter. Although the percentage of mononuclear leukocytes (macrophages and lymphocytes) decreased in both strains after LPS, absolute numbers increased such leukocytes increased Ͼ10-fold in both strains (P Ͻ 0.001), due primarily to the influx of neutrophils. In both strains, leukocyte numbers remained elevated throughout the 96-h testing period. Although neutrophils remained the predominant cell type at all time points after LPS exposure, mononuclear leukocytes also increased. PMN, polymorphonuclear leukocyte; lymph, lymphocyte; eos, eosinophil; mac, macrophage. Values were similar in the 2 strains at baseline. After LPS exposure, G (P ϭ 0.002 for C57BL/6 and P ϭ 0.003 for 129/J mice at 24 h) and H (P ϭ 0.001 for C57BL/6 and P ϭ 0.001 for 129/J mice at 24 h) increased significantly, whereas Raw did not change.
that at 96 h, the number of macrophages plus lymphocytes was four-to fivefold greater than baseline (C57BL/6: 0.59 Ϯ 0.06 to 2.36 Ϯ 0.45 ϫ 10 5 cells/ml, P Ͻ 0.001 and 129/J: 0.28 Ϯ 0.06 to 2.61 Ϯ 0.43 ϫ 10 5 cells/ml, P Ͻ 0.001).
Evidence of capillary leakage after nebulized LPS. Inhaled LPS treatment caused a graded increase in BAL total protein content among both 129/J and C57BL/6 mice (Fig. 3) . In both strains, peak protein levels were observed after 96 h of LPS exposure (C57BL/6: 111 Ϯ 129 mg/ml at baseline to 1,236 Ϯ 223 mg/ml at 96 h, P Ͻ 0.001; 129/J: 59 Ϯ 36 mg/ml at baseline to 865 Ϯ 160 mg/ml at 96 h).
Lung wet weight normalized to body weight is summarized in Fig. 4 . Increases paralleled changes in BAL protein levels and corresponded with the number of LPS exposures. Measurements at 48 (C57BL/6: 19.2 Ϯ 0.8 mg/g; 129/J: 17.8 Ϯ 3.4 mg/g) and 96 (C57BL/6: 23.7 Ϯ 1.9 mg/g; 129/J: 26.8 Ϯ 1.8 mg/g) h were significantly different from baseline (C57BL/6: 12.8 Ϯ 1.6 mg/g; 129/J: 14.3 Ϯ 2.5 mg/g) in both strains. Peak increases, observed at 96 h, were 1.5-to-2-fold times baseline, similar to values reported among patients with ALI (22) .
Changes in BAL cytokines after nebulized LPS. BAL levels of inflammatory cytokines were similar among the two strains of mice (Fig. 5) . After LPS exposure, TNF-␣ and IL-6 BAL levels increased rapidly. TNF-␣ levels increased within 2 h after LPS exposure and returned toward baseline by 24 h in a pattern consistent with that previously described (1, 21, 22) . IL-6 increased by 2 h and remained persistently elevated at all subsequent time points. INF-␥, IL-10, and IL-1␤ increased more gradually, but levels were slightly greater with each successive LPS exposure, suggesting the potential for continued increase beyond 96 h.
Alteration in VEGF and Ang expression after nebulized LPS. Protein expression for VEGF, Ang-4, and Ang-2 was analyzed using immunostaining. Results of immunoperoxidase staining for C57BL/6 mice are summarized in Figs. 6 (VEGF), 7, 8 (Ang-4), and 9 (Ang-2). At baseline, VEGF (Fig. 6, A and D) , Ang-4 (Fig. 7 , A and C), and Ang-2 (Fig. 9, A and D) were readily detected in the airway epithelium and in the alveolar epithelial cells. Immunostaining patterns for VEGF and Ang-4 changed substantially after exposure to inhaled LPS. VEGF increased within the alveolar compartment of both strains after sequential LPS exposures, with the greatest intensity noted in the 96-h samples (Fig. 6, B and E) . The increases in immunoreactivity were due to greater numbers of peripheral Fig. 3 . BAL total protein content after LPS exposure is summarized. Protein levels, used as an index of capillary permeability, steadily increased with successive LPS doses. In both strains (C57BL/6 and 129/J), compared with baseline, peak levels were observed at 96 h after 4 doses of inhaled LPS (P Ͻ 0.001). (Fig. 6, C and F) . The staining patterns for 129/J mice were similar to those observed in the C57BL/6 mice (data not shown).
By contrast, immunostaining for Ang-4 in C57BL/6 mice ( Fig. 7) was readily detectable in the alveolar compartment and airway epithelium at baseline (Fig.   7 , A and C) but decreased with successive exposures to LPS. The greatest decrease in immunopositive cells was noted in 96-h samples and involved both the bronchial epithelial cells and cells within the alveolar compartment (Fig. 7, B and D) . Preabsorbing the primary antibody with specific peptide ablated the immunostaining for Ang-4 (Fig. 8, A-D ) . These staining patterns were observed in both C57BL/6 and 129/J mice.
Immunostaining for Ang-2 was abundant at baseline (Fig. 9, A and D) . Similar to Ang-4 immunostaining, Ang-2 was expressed by both bronchial epithelial cells and cells within the alveolar compartment. In C57BL/6 mice, the pattern for Ang-2 after LPS exposure differed from both VEGF and Ang-4 in that epithelial cell immunoreactivity decreased (Fig. 9B ), but immunoreactivity within alveolar cells increased (Fig. 9E) at Immunostaining is ablated after preabsorbing the primary antibody against specific peptide (F). Magnification, ϫ400.
96 h. Staining of serial sections with CD45 demonstrated that the increased distal immunostaining was largely due to increased macrophage expression (data not shown). In 129/J mice, there was little change in the Ang-2 immunostaining after LPS (data not shown).
We then examined whether alterations in VEGF and Ang-4 and Ang-2 protein expression were associated with similar changes in mRNA expression. In addition, levels of mRNA encoding Ang-1 were assessed. Messenger RNA levels assayed by RT-PCR are summa- rized in Fig. 10 for both 129/J and C57BL/6 mice. Similar responses to LPS were observed between both strains, with VEGF mRNA tending to increase, whereas levels of Ang-1 and Ang-4 tended to decrease.
At baseline, mRNA encoding VEGF was detected at low levels. After exposure to LPS, this mRNA increased at the 24-h time point and remained elevated at 48 and 96 h. The mRNA encoding Ang-1 was abundantly expressed at baseline and became undetectable in C57BL/6 mice by the 48-h time point. A similar pattern was observed in 129/J mice, with the mRNA encoding Ang-1 becoming markedly decreased, but still detectable, by 96 h. The mRNA encoding Ang-4 was similarly decreased at 48 and 96 h in both strains. Thus the patterns of expression for the mRNAs encoding VEGF, Ang-1, and Ang-4 paralleled those observed with immunostaining for VEGF and Ang-4. This suggests that the increased (or decreased) immunostaining reflects increased protein expression due to increased (or decreased) transcription. In contrast, the total mRNA encoding Ang-2 was slightly decreased at the 48-h time point in the C57BL/6 mice and was largely unchanged after LPS exposure in the 129/J mice. Levels of the housekeeping gene ␤-actin were unchanged after LPS exposure.
DISCUSSION
Vascular growth factors, which include VEGF, Ang-1, Ang-2, and Ang-4, are known to regulate vasculogenesis and angiogenesis during embryonic development as well as new vessel growth and proliferation in certain tumors and during tissue healing (26) . More recently, it has been demonstrated that these peptides modulate epithelial integrity in adult vascular beds and influence the course of diseases in which vascular leakage is important. Systemic expression of VEGF has been shown to cause widespread multiorgan cap- illary leakage, an effect that is attenuated by concomitant expression of Ang-1 (23). Ang-1 has also been shown to abrogate capillary leakage within the dermis after administration of nonspecific irritants (22) . Together, these observations suggest that a balance between the proleakage effects of VEGF and antileakage effects of the angiopoietins, in part, modulates vascular integrity and ultimately oxygen delivery. The present study examines the role of VEGF and the angiopoietins in modulating capillary leakage and inflammation during the development of ALI after LPS exposure.
To examine this question, we utilized a previously validated murine model (10) that closely replicates many of the physiological and biological aspects of human ALI (8) . In two common strains of mice (C57BL/6 and 129/J), nebulized LPS produced two-to fivefold increases in tissue resistance and dynamic elastance and smaller changes in airway resistance. The magnitude of change in physiological parameters was more pronounced in 129/J mice than in C57BL/6 mice, although patterns were similar in both and paralleled changes in human patients with ALI/acute respiratory distress syndrome (ARDS) in which the predominant abnormality involves the parenchyma. The marked frequency dependence of elastance indicates physiological heterogeneity, also a characteristic of ALI (2) .
LPS exposure was associated with cellular inflammation and an increase in BAL cytokines. The large increase in total cells was due primarily to a rise in the number of neutrophils. BAL levels of TNF-␣, IL-1␤, IL-6, and IFN-␥ increased in both strains after LPS exposure, consistent with acute inflammation. The patterns of cytokine expression in BAL fluid were similar among the two strains. TNF-␣ levels peaked within hours of LPS exposure, returning toward normal within 24 h, whereas IL-1␤, IL-6, and IFN-␥ increased steadily with sequential exposures. Together, these observations confirm that both C57BL/6 and 129/J mice develop an inflammatory response to LPS physiologically and biologically similar to ALI.
We further show that this inflammatory response is accompanied by pronounced capillary leakage. Lavage fluid protein, a nonspecific marker of breakdown in the epithelial-endothelial barrier, was significantly elevated after LPS exposure at all time points compared with baseline. Protein levels increased with serial LPS exposures. Lung weights normalized to body weight also progressively increased with each LPS dosage. In both C57BL/6 and 129/J mice, lung weight doubled by 96 h.
The extent of the physiological and biological responses to LPS were substantially greater in the 129/J mice compared with the C57BL/6 mice. In this context, it is notable that the patterns of expression for VEGF and the angiopoietins following LPS in these two strains are remarkably similar. The pattern is consistent with the observed changes in lung wet-to-dry ratios, which correlates with the degree of pulmonary edema in this model. These findings suggest that the changes in the expression patterns of vascular growth pattern are likely not strain dependent but are probably part of the pulmonary response to inhaled LPS in this model of murine ALI. These data are also consistent with the hypothesis that the vascular growth factors, VEGF and the angiopoietins, modulate capillary permeability in ALI. Of note, the changes in cytokine expression, BAL cellular profiles and total protein, elastance, and tissue resistance preceded the changes in the vascular growth factor mRNA. There are at least two possible reasons for this observation. RT-PCR is a semiquantitative technique, so small changes in gene expression between groups may not have been detected. Alternatively, alterations in vascular growth factor expression may be one of several concurrently acting processes contributing to the pathophysiology of ALI.
To test the hypothesis that LPS induces differential protein expression of VEGF and the angiopoietins, immunostaining was performed. Our data demonstrate that after LPS and coincident with the development of inflammation, capillary leakage, and lung edema, VEGF expression increased significantly in resident mononuclear cells and neutrophils within the lung parenchyma. VEGF was also detected in the bronchial epithelium but was unchanged from baseline after exposure to LPS. The increased immunostaining was paralleled by increased mRNA expression, consistent with a transcriptional mechanism for the alterations in VEGF expression. This is supported by the increased intensity of immunostaining for VEGF within mononuclear inflammatory cells after exposure to LPS compared with the immunostaining detected in the mononuclear inflammatory cells in untreated lung tissue samples. However, we cannot exclude an increase in the overall expression of mRNA encoding VEGF due solely to the influx of inflammatory cells after exposure to inhaled LPS. By contrast, Ang-4 immunostaining, which was readily evident at baseline, decreased over time after LPS exposure as lung inflammation progressed. In control samples, Ang-4 staining was demonstrated predominantly by epithelial cells, and to a lesser extent by interstitial cells, but not by resident pulmonary macrophages or neutrophils. After LPS exposure, Ang-4 expression by epithelial cells decreased substantially. As observed with VEGF, the decreased immunostaining was paralleled by decreased mRNA expression, consistent with a transcriptional mechanism for the alteration in Ang-4 expression. Immunostaining for Ang-2, which is associated with increased vascular permeability, did not change after LPS exposure in 129/J mice. In C57BL/6 mice, bronchiolar epithelial immunostaining for Ang-2 decreased, but peripheral mononuclear cell staining increased after LPS exposure. Thus in the C57BL/6 mice, Ang-2 immunostaining increased in the alveolar compartment, which is the site of capillary leakage in pulmonary edema. In these animals, the mRNA for Ang-2 did not substantially change in the 129/J mice and showed a slight decrease in the C57BL/6 mice at the 48-h time point baseline, which may reflect the divergent expression patterns observed in airway and parenchymal cells after endotoxin.
The pattern of VEGF upregulation accompanied by Ang-1 and Ang-4 downregulation after LPS exposure within the lung is consistent with patterns previously reported to promote capillary leakage and tissue edema in other organs (11, 27) . This suggests that the relative balance between proleakage (VEGF and Ang-2) and antileakage (Ang-1 and Ang-4) vascular growth factors may be important in the determination of capillary integrity. That is, changes in any given factor may be less important than the overall balance between the two types of factors. Overexpression of VEGF induces plasma leakage (11) through binding to the endothelial cell-specific tyrosine kinase receptor flk-1/VEGF-R2 (16) . VEGF-R2 activation leads to phosphorylation of AJC proteins (4, 6, 21) , decreased association between VE-cadherin and intracellular catexin, and a weakening of intercellular junctions with increased paracellular leakage (4). In contrast, Ang-1, which promotes stabilization of endothelial junctional complexes (4, 7), was downregulated in our model. Other investigators have shown that Ang-1 promotes vascular integrity even in the face of increased VEGF expression (4, 7) . Our data suggest that the combination of decreased Ang-1 and increased VEGF might favor capillary leakage due to unopposed action of VEGF on the endothelium. In addition, Ang-4, which is known to be specifically expressed in lung tissue but has not previously been examined in the context of a model of ALI, is also decreased in this model. We speculate that, similar to Ang-1, Ang-4 may modulate pulmonary vascular integrity.
Our findings are in agreement with those of Thickett and colleagues (21) who demonstrated that plasma VEGF was significantly elevated in patients with ARDS compared with patients who had risk factors to develop ARDS, normal control subjects, and ventilated patients without ARDS. In the same study, peripheral blood monocytes from patients with ARDS produced significantly more VEGF in vitro than those of at risk patients. In addition, albumin flux across human pulmonary endothelial cell monolayers was significantly increased after the addition of plasma from patients with ARDS compared with plasma from controls, an effect that was partially inhibited by the addition of a soluble VEGF inhibitor (21) .
In contrast, a recent study by Maitre and colleagues (14) showed decreased levels of VEGF expression in a rat model of infection-associated severe lung injury and in the BAL from patients with early ARDS. Although these results would appear to conflict with the current study, there are several important methodological differences between the two studies. First, the investigation by Maitre and colleagues (14) examined rat lung tissue and human BAL, whereas the current study examines murine tissue. Also, the expression of mediators in BAL may not be completely representative of the expression of mediators in the tissue compartment. Also, the kinetics of the two studies differ in that Maitre and colleagues focused on very early time points, whereas the current study focused on a longer time course.
The observations presented here do not prove a causal role for these vascular growth factors in the pathophysiology of ALI. In contrast to other organs in which the endothelium represents the primary barrier to capillary leakage and vascular growth factors appear to play a dominant regulatory function, the lung has a dual epithelial-endothelial barrier. The epithelial barrier has traditionally been recognized as being primarily responsible for regulating fluid balance within the lung. Therefore, it is unclear whether isolated disruption of the endothelial barrier would be sufficient to allow capillary leakage of the type that occurs in ALI. Nevertheless, alterations in the endothelial barrier are ultimately necessary to allow marked changes in permeability. It is, therefore, interesting that the pulmonary epithelial cell appears to be primarily responsible for expression of Ang-1 and Ang-4. This expression pattern suggests that the epithelium is an important regulator of the state of "leakiness" of the endothelial barrier, and thus permeability of the serially aligned epithelial-endothelial barrier systems may change in a synchronous fashion. Decreases in Ang-1 and Ang-4, resulting from changes in epithelial cell expression due to cell death or altered rates of synthesis and/or secretion, might act permissively to increase permeability. Although this regulatory configuration facilitates a rapid immunological response to alveolar pathogens by permitting transcapillary access for neutrophils, complement proteins, serum immunoglobulins, and fibrin, it also tends to promote development of exudative pulmonary edema as seen in ALI and described here in our animal model. In summary, our study demonstrates that inhaled LPS causes physiological and biological responses in mice similar to those reported in human ALI. The observed neutrophil infiltration, capillary leakage, and lung edema are accompanied by increased production of VEGF and downregulation of Ang-1 and Ang-4 in a time-and dose-dependent manner. Further studies are required to clarify the potential mechanisms regulating expression of these vascular growth factors as well as their direct mode of action on the lung endothelium, both under physiological conditions and during acute inflammation. Our results suggest that the differential expression of VEGF, Ang-1, Ang-2, and Ang-4 by activated mononuclear phagocytes, neutrophils, and epithelial cells within the lung may contribute to the development of ALI.
